Images List Premium Download Classic

Weight Loss

Weight Loss-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Method and apparatus for predicting one or more parameters characteristic for the outcome of a ...
Fresenius Medical Care Deutschland Gmbh
October 12, 2017 - N°20170290969

The present invention relates to a method and to an apparatus for predicting one or more parameters characteristic for the outcome of a blood treatment, wherein the blood treatment is a treatment in which the blood of the patient has fluid removed via at least one membrane, wherein the parameters are the allowed drinking volume, the hyperhydration or hypohydration of ...
Curable benzoxazine compositions with improved thermal stability
3m Innovative Properties Company
October 05, 2017 - N°20170283558

A curable benzoxazine composition is described wherein the benzoxazine is derived from an aryl amine having a b. P.>200° c. The curable compositions are more thermally stable and have reduced weight loss and by-products upon cure.
Incretin-insulin conjugates
Indiana University Research And Technology Corporation
October 05, 2017 - N°20170281788

Disclosed herein are insulin agonist peptides conjugated to incretins wherein the incretin-insulin conjugate has agonist activity at the insulin receptor and the corresponding incretin receptor, and stimulates weight loss in an individual administered the compound.
Weight Loss Patent Pack
Download + patent application PDFs
Weight Loss Patent Applications
Download + Weight Loss-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Weight Loss-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Cooling system for electronic equipment
Exascaler Inc.
September 21, 2017 - N°20170273223

A cooling system is adapted for reduction of evaporative loss of a liquid coolant and for efficient cooling of plural electronic devices densely accommodated in a cooling bath of a small volume. A cooling system accommodates plural electronic devices in an open space of a cooling bath provided with an inlet port and an outlet port for a liquid coolant. ...
Methods and compositions for weight control
4life Patents, Llc
September 21, 2017 - N°20170266249

Methods and compositions for providing control over a subject's body, include methods and compositions for enhancing the ability of a subject's body to lose weight, or for inducing weight loss in the subject's body. Such methods and compositions may induce thermogenesis in the adipocytes of a subject's body, enhancing the subject's metabolism, inhibit adipogenesis in adipocytes of the individual, and ...
Compositions and methods for producing elevated and sustained ketosis
University Of South Florida
September 21, 2017 - N°20170266148

Beta-hydroxybutyrate mineral salts in combination with medium chain fatty acids or an ester thereof such as medium chain triglycerides were used to induce ketosis, achieving blood ketone levels of (2-7 mmol/l), with or without dietary restriction. The combination results in substantial improvements in metabolic biomarkers related to insulin resistance, diabetes, weight loss, and physical performance in a short period ...
Weight Loss Patent Pack
Download + patent application PDFs
Weight Loss Patent Applications
Download + Weight Loss-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Weight Loss-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Corrosion inhibition
Schlumberger Technology Corporation
August 24, 2017 - N°20170240796

A method of inhibiting corrosion of duplex stainless steel by aqueous acidic solution, comprises carrying out a preliminary treatment which is passivation of the steel while exposing the steel to a first aqueous acidic solution containing at least one organic corrosion inhibitor able to adsorb to a steel surface, so as to deposit a passivating and corrosion inhibiting film on ...
Combination treatment of sglt2 inhibitors and dopamine agonists for preventing metabolic disorders in equine animals
Boehringer Ingelheim Vetmedica Gmbh
August 24, 2017 - N°20170239281

The present invention relates to combination of one or more sglt2 inhibitors or pharmaceutically acceptable forms and/or salts thereof and one or more dopamine receptor agonists or pharmaceutically acceptable forms and/or salts thereof, preferably in the treatment and/or prevention of a metabolic disorder of an equine animal, wherein more preferably the metabolic disorder is one or more ...
Methods and devices for activating brown adipose tissue using electrical energy
The General Hospital Corporation D/b/a/ Massachusetts General Hospital
August 17, 2017 - N°20170232254

Methods and devices are provided for activating brown adipose tissue (bat). Generally, the methods and devices can activate bat to increase thermogenesis, e. G., increase heat production in the patient, which over time can lead to weight loss. In one embodiment, a medical device is provided that activates bat by electrically stimulating nerves that activate the bat and/or electrically ...
Novel compositions and methods useful for treating or preventing liver diseases or disorders, and promoting ...
Yale University
August 17, 2017 - N°20170232027

The invention includes a method of preventing or treating a toxic liver disease or disorder, such as but not limited to non-alcoholic steatohepatitis (nash), liver injury associated with or caused by alcohol consumption in a mammal afflicted with nash, alcoholic hepatitis, drug induced liver injury, primary sclerosing cholangitis, viral hepatitis, liver fibrosis, liver cirrhosis, and other toxic liver conditions, in ...
Magnetic satiety inducing system
Yale University
August 17, 2017 - N°20170231791

A minimally invasive system and method for providing weight loss by inducing the feeling of satiety whereby an intragastric device is inserted into the gastric lumen via the esophagus and an external magnetic device is used as needed to magnetically attract the intragastric device towards the inner wall of the stomach and impart tactile stimulation sufficient to induce the feeling ...
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery ...
Yale University
August 10, 2017 - N°20170224911

Systems and methods for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and treating hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, attention deficit disorder and nicotine addiction involve synchronizing and tailoring the administration of nutraceuticals, medications and other substances in accordance with the body's natural circadian rhythms, meal times and other factors. Improved control of blood ...
Systems and methods to affect the flow of chylomicron lipids
Boston Scientific Scimed, Inc.
August 10, 2017 - N°20170224512

The present disclosure relates to the field of weight loss. Specifically, the present disclosure relates to systems and methods for reducing daily caloric loads by limiting the delivery of long chain fatty acids into the bloodstream. More specifically, the present disclosure relates to systems and methods for reducing or restricting the flow of chylomicron lipids from the cysterna chyli through ...
Weight Loss Patent Pack
Download + patent application PDFs
Weight Loss Patent Applications
Download + Weight Loss-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Weight Loss-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Hsp90 inhibitors for the treatment of obesity and methods of use thereof
The Children's Medical Center Corporation
July 27, 2017 - N°20170209408

Hsp 90 inhibitors for the promotion of weight loss, as well as formulations containing these inhibitors and methods of using thereof, are described herein. Also provided are pharmaceutical compositions containing a therapeutically effective amount of a weight loss agent, or a pharmaceutically acceptable salt or prodrug thereof, in combination with one or more pharmaceutically acceptable excipients. The pharmaceutical compositions can be ...
Predicting weight loss and fat metabolism using optical signal changes in fat
The Regents Of The University Of California
July 27, 2017 - N°20170209089

A quantitative, non-invasive optical spectroscopy technique for measuring dynamic changes in adipose tissue structure and metabolism in vivo. The technique requires multiple wavelengths of light in the near-infrared (650-1000 nm). Using these wavelengths of light, adipose tissue is illuminated and light that returns to a photodetector is analyzed. From the return signals, the absorption and reduced scattering coefficients (μ...
Core 22 human training and weight loss system
The Regents Of The University Of California
July 13, 2017 - N°20170200392

The system of the preferred embodiments is a method for human training coordinated by a computer interface, where a human user interacts with at least one computing interface; where the at least one computing is provided by a computing device having at least one processor, computer readable storage medium, and a network connection to at least one additional computing device; ...
Oxyntomodulin analogs and methods of making and using same
California Institute For Biomedical Research
July 13, 2017 - N°20170196940

Provided are oxyntomodulin analogs. The peptide analogs have at least two cysteines. The two cysteines are separated by six amino acids such that they can be crosslinked using suitable crosslinking moieties. The crosslinked peptides have long half-lives and/or efficacy. For example, peptide analog compositions are used for inducing weight loss and/or reducing blood glucose levels.
Implantable weight control device to promote early and prolonged satiety in a bariatric patient
Agt Inc.
July 13, 2017 - N°20170196719

The present disclosure provides an inflatable weight control device that is implanted long-term with an endoscope in obese and bariatric human patients to promote early and prolonged satiety. The device includes a flexible member coupled to a valve body assembly and an elongated durable module residing within the flexible member. The flexible member is selectively inflated to form two bulbs ...
Heat and flame resistant polyurethane foam
Dow Global Technologies Llc
July 06, 2017 - N°20170190827

The present invention relates to a reactive formulation used to make a heat and flame resistant flexible polyurethane foam which is particularly suited for use in under the hood vehicle applications which require sound deadening and vibration management and a process to make said foam. Said foam is particularly suitable for such applications because desirable heat and flame resistant properties ...
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery ...
Dow Global Technologies Llc
June 29, 2017 - N°20170182299

Systems and methods for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and treating hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, attention deficit disorder and nicotine addiction involve synchronizing and tailoring the administration of nutraceuticals, medications and other substances in accordance with the body's natural circadian rhythms, meal times and other factors. Improved control of blood ...
Compositions and methods for increasing the suppression of hunger and reducing the digestibility of non-fat ...
University Of Copenhagen
June 22, 2017 - N°20170173099

The present invention relates to methods for increasing the suppression of hunger and/or increasing the reduction of prospective consumption and/or increasing the reduction of appetite and/or increasing the feeling of satiety and/or reducing non-fat energy uptake in the gastrointestinal tract of a mammal in order to prevent a positive non-fat energy balance, weight gain, overweight and ...
Loading